BIT 5.26% 2.0¢ biotron limited

I don't want to rain on anyone's parade here but am I missing...

  1. 124 Posts.
    lightbulb Created with Sketch. 20
    I don't want to rain on anyone's parade here but am I missing something, where is the clinical data from the late SEP ASX release.

    How does the recent ASX release support an increase in Market Cap from $9M to $87M ?  Oh, I forgot right there are 78M NOV 6c options coming up for expiry - LOL

    BIT directors need to be very careful here IMO and should be consulting GSW's new governance manual regarding ASX releases - LOL again !

    I wouldn't be surprised to see a clarification request from ASX here in the short term.

    Watch out below !

    PS. I would be happy to buy BIT at 14c if the data showed clinical benefit and the PII trial reached its end-points but this could only be judged AFTER one reviewed the data

    As long as everyone realizes that they're playing red or black here all good !  ATB
    Last edited by Distressed Player: 11/10/18
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.